Incidence and cost of treatment-emergent comorbid events in insured patients with chronic hepatitis C virus infection: a retrospective cohort study

BACKGROUND: Treatment-emergent comorbid events (TECs) are common In patients initiating treatment with pegylated interferon alpha (PEG-IFN-alfa) and ribavirin for chronic hepatitis C virus (HCV) infection. The purpose of this study was to estimate the incidence and incremental cost of these events....

Descripción completa

Detalles Bibliográficos
Autores principales: Sapra, Sandhya, Chang, Eunice, Broder, Michael S, L’Italien, Gilbert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4263056/
https://www.ncbi.nlm.nih.gov/pubmed/25249187
http://dx.doi.org/10.1186/1472-6963-14-429

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4263056/
https://www.ncbi.nlm.nih.gov/pubmed/25249187
http://dx.doi.org/10.1186/1472-6963-14-429

Ejemplares similares